Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • AltheaDx management update

    AltheaDx Inc., San Diego, Calif. Business: Diagnostic, Supply/Service Hired: Juan-Sebastian Saldivar as CMO, formerly VP of clinical services and medical affairs at Sequenom Inc.s Sequenom Laboratories subsidiary

    Published on 12/8/2014
  • Arca biopharma management update

    ARCA biopharma Inc. (NASDAQ:ABIO), Broomfield, Colo. Business: Cardiovascular Departing: Patrick Wheeler as CFO, effective Dec. 31 Promoted: Thomas Keuer, EVP of pharmaceutical operations, to COO

    Published on 12/8/2014
  • Ardelyx management update

    Ardelyx Inc. (NASDAQ:ARDX), Fremont, Calif. Business: Gastrointestinal, Renal, Endocrine/Metabolic Hired: Jeremy Caldwell as EVP and CSO, formerly an entrepreneur-in-residence at Third Rock Ventures; he succeeds …

    Published on 12/8/2014
  • Ascendis board of directors update

    Ascendis Pharma A/S, Hellerup, Denmark Business: Drug delivery Appointed: Albert Cha, managing partner at Vivo Capital; James Healy, general partner at Sofinnova Ventures; and Jonathan Silverstein, partner and co-head …

    Published on 12/8/2014
  • Audentes Therapeutics board of directors update

    Audentes Therapeutics Inc., San Francisco, Calif. Business: Musculoskeletal, Endocrine/Metabolic, Gene/Cell therapy Appointed: Jonathan Leff, partner on the private transactions team at Deerfield Management

    Published on 12/8/2014
  • AyoxxA management update

    AyoxxA Biosystems GmbH, Cologne, Germany Business: Mircoarrays Hired: Andreas Richter as CFO, effective Jan. 1, 2015

    Published on 12/8/2014
  • Cara management update

    Cara Therapeutics Inc. (NASDAQ:CARA), Shelton, Conn. Business: Neurology Hired: Joseph Stauffer as CMO, formerly CMO of Ikaria Inc.

    Published on 12/8/2014
  • Cortendo management update

    Cortendo AB, Gothenburg, Sweden Business: Endocrine/Metabolic Hired: Ruth Thieroff-Ekerdt as CMO, effective Dec. 15, formerly CMO of Aptalis Pharma Inc., which Forest Laboratories Inc. acquired; Actavis plc subsequently…

    Published on 12/8/2014
  • Dimension Therapeutics management update

    Dimension Therapeutics, Cambridge, Mass. Business: Gene/Cell therapy, Hematology Hired: Eric Crombez as CMO, a newly created position, formerly senior medical director of clinical global development at Shire plc

    Published on 12/8/2014
  • Endonovo Therapeutics management update

    Endonovo Therapeutics Inc. (OTCQB:ENDV), Woodland Hills, Calif. Business: Inflammation, Autoimmune Hired: Randolph Johnson as EVP of clinical development and chief development officer, formerly president and CEO of …

    Published on 12/8/2014
  • Fred Hutchinson management update

    Fred Hutchinson Cancer Research Center, Seattle, Wash. Business: Cancer Hired: Gary Gilliland as president and director, effective Jan. 2, 2015, formerly VP of precision medicine at the University of Pennsylvanias …

    Published on 12/8/2014
  • Idera management update

    Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass. Business: Cancer, Infectious, Autoimmune Hired: Vincent Milano as CEO and a director, formerly president, CEO and chairman of ViroPharma Inc., which Shire plc …

    Published on 12/8/2014
  • Intellipharmaceutics management update

    Intellipharmaceutics International Inc. (TSX:I; NASDAQ:IPCI), Toronto, Ontario Business: Drug delivery Hired: Domenic Della Penna as CFO, formerly CFO of Teva Pharmaceutical Industries Ltd.s Teva Canada Ltd. subsidiary;…

    Published on 12/8/2014
  • Klox Technologies management update

    Klox Technologies Inc., Laval, Quebec Business: Dermatology Hired: Todd Martensen as chief commercial officer, a newly created position, formerly VP of sales in the Americas for the medical division at Leica …

    Published on 12/8/2014
  • Lundbeck management update

    H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Business: Neurology Resigned: Ulf Wiinberg as president and CEO; Chairman Hakan Bjorklund becomes interim CEO

    Published on 12/8/2014
  • Medivation management update

    Medivation Inc. (NASDAQ:MDVN), San Francisco, Calif. Business: Cancer Hired: Joseph Lobacki as chief commercial officer, formerly general manager of the oncology business at Idera Pharmaceuticals Inc.; he succeeds Dawn …

    Published on 12/8/2014
  • Mela Sciences management update

    MELA Sciences Inc. (NASDAQ:MELA), Irvington, N.Y. Business: Diagnostic Resigned: Rose Crane as president, CEO and a director; she is succeeded, effective Dec. 15, by Michael Stewart, a director at MELA, and formerly EVP…

    Published on 12/8/2014
  • Minerva Neurosciences management update

    Minerva Neurosciences Inc. (NASDAQ:NERV), Cambridge, Mass. Business: Neurology Transitioned: Remy Luthringer to CEO and a director, while remaining president and CSO; he succeeds Rogerio Vivaldi

    Published on 12/8/2014
  • Novo Nordisk management update

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Pharmaceuticals Departed: Lise Kingo as EVP and chief of staffs

    Published on 12/8/2014
  • Oxis management update

    Oxis International Inc. (OTCBB:OXIS; Euronext:OXI), Beverly Hills, Calif. Business: Nutraceuticals, Autoimmune, Inflammation Resigned: Ken Eaton as CEO and a director Transitioned: Anthony Cataldo to CEO, while …

    Published on 12/8/2014
  • PMV Pharmaceuticals board of directors update

    PMV Pharmaceuticals Inc., Redwood City, Calif. Business: Cancer, Infectious Appointed: Peter Thompson, private equity partner at OrbiMed

    Published on 12/8/2014
  • QLT management update

    QLT Inc. (TSX:QLT; NASDAQ:QLTI), Vancouver, Beta.C. Business: Ophthalmic, Drug delivery Resigning: Sukhi Jagpal as CFO, effective Jan. 26, 2015

    Published on 12/8/2014
  • Quantum Genomics management update

    Quantum Genomics Corp. (Euronext:ALQGC), Massy, France Business: Cardiovascular Hired: Olivier Madonna as CMO

    Published on 12/8/2014
  • RaNATherapeutics management update

    RaNA Therapeutics Inc., Cambridge, Mass. Business: Pharmacogenetics Hired: Ronald Renaud as CEO and a director, formerly president and CEO of Idenix Pharmaceuticals Inc., which Merck & Co. Inc. acquired

    Published on 12/8/2014
  • Rigel management update

    Rigel Pharmaceuticals Inc. (NASDAQ:RIGL), South San Francisco, Calif. Business: Autoimmune, Cancer, Inflammation Resigned: James Grower as CEO and chairman; he is succeeded as chairman by Gary Lyons, a director, and as …

    Published on 12/8/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993